Next Article in Journal
Pediatric Spinal Solitary Fibrous Tumor: A Systematic Review of a Rare Condition
Previous Article in Journal
Risk Factors for Early Neonatal Hypocalcemia in Preterm Neonates Born After 32 Weeks Gestation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Children
Volume 12
Issue 9
10.3390/children12091212
children-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Viral and Bacterial Etiology of Common Respiratory Infections in Children in Sub-Saharan Africa: A Systematic Review

by
Jordy Exaucé Demboux Lyelet
1,2,
Pembe Issamou Mayengue
1,2,3,*,
Félix Koukouikila-Koussounda
1,2,
Eric M. Leroy
4,
Pierre Becquart
5 and
Fabien Roch Niama
1,2
1
Faculty of Sciences and Technics, Marien Ngouabi University, Brazzaville BP 69, Democratic Republic of the Congo
2
National Public Health Laboratory, Brazzaville BP 20, Democratic Republic of the Congo
3
National Institute for Research in Engineering Science, Innovation and Technology (INRSIIT), Brazzaville Scientific City, Brazzaville BP 181, Democratic Republic of the Congo
4
UMR TransVIHMI Montpellier University-IRD-Inserm, Montpellier University, 34394 Montpellier, France
5
Infectious Diseases and Vectors: Ecology, Genetic, Evolution and Control (MIVEGEC), Institute for Research for Development (IRD), Montpellier University, CNRS, 34394 Montpellier, France
*
Author to whom correspondence should be addressed.
Children 2025, 12(9), 1212; https://doi.org/10.3390/children12091212
Submission received: 12 August 2025 / Revised: 29 August 2025 / Accepted: 2 September 2025 / Published: 10 September 2025
(This article belongs to the Section Pediatric Pulmonary and Sleep Medicine)
Browse Figures
Versions Notes

Abstract

Background/Objectives: Respiratory infections are a major global public health problem, with potentially serious consequences. Indeed, they remain one of the main causes of morbidity and mortality in children under 5 in developing countries. Etiological information on respiratory infections is crucial for prevention and case management strategies. This review describes the etiology of respiratory infections reported in studies conducted in sub-Saharan African countries. Methods: PubMed, HINARI and Google Scholar search engines were used for bibliographic research, and only data from sub-Saharan Africa were considered. Articles published between 2010 and 2023, in English or French, were included in this review. Results: After a thorough search, 2175 documents were identified. Critical review and removal of duplicates identified 347 full-text studies, which underwent rigorous evaluation. A total of 50 articles were retained, with studies conducted in 24 sub-Saharan African countries, most of them in Cameroon (12%). Thirty-three (66%) were cross-sectional studies, and thirty-seven (74%) were hospital-based surveys. Respiratory syncytial virus was most frequently identified (0.6% to 59%), followed by rhinovirus (7.5% to 73%). The most frequent bacteria were Streptococcus pneumoniae (1–96%) and Haemophilus influenzae (2.5–54%). Conclusions: This study suggests that acute respiratory infections in sub-Saharan Africa, mainly in children, are primarily caused by viruses and a few bacteria.

1. Introduction

Respiratory viral infections are increasingly recognized as major contributors to hospitalization and mortality in all age groups worldwide, with a serious form of illness particularly in infants and immunocompromised individuals [1,2]. Annually, lower respiratory tract infections (LRTIs) cause approximately four million deaths worldwide and impart annual global inpatient and outpatient costs of approximately EUR 5 billion [3,4].
Most epidemiological knowledge is based on data from developed countries. In contrast, the burden of acute respiratory infections (ARI) is particularly heavy among children in developing countries, with high rates of hospital admissions and mortality [5,6]. Indeed, it is estimated that about 126 to 156 million cases of acute lower respiratory tract infections (ALRTI) such as pneumonia and bronchiolitis occur in children worldwide each year, causing around 1.4 million deaths, over 95% of which occur in Africa and Southeast Asia [7].
Upper respiratory tract infections are commonly caused by viruses or bacteria. Respiratory viruses are more often responsible for upper tract ARIs than bacteria in children under 5 years of age [6]. Common symptoms include nasal congestion, cough, sore throat, and fever. However, bacteria are less identified because of low sensitivity of bacterial culture, particularly in patients with community-acquired pneumonia [8]. Respiratory viruses such as respiratory syncytial virus, Influenza viruses (A and B), parainfluenza viruses, human adenovirus, human coronaviruses OC43 and 229E, rhinovirus and metapneumovirus are currently recognized as common etiologies of ARI in young children in developed countries [5].
Recent use of molecular diagnostic techniques has identified other respiratory viruses associated with ARI, including human metapneumovirus, human Bocavirus, human coronavirus NL63, and human coronavirus HKU1 [6]. In addition, human rhinovirus is implicated in the majority of cold cases and often induces lower respiratory tract infections [6]. A better understanding of the range of pathogens responsible for ARI is therefore essential for clinical case management and the design of preventive strategies aimed at reducing childhood morbidity and mortality.
Lower respiratory tract infection (LRTI) is common in the elderly, children under five years of age and people who are immunocompromised or suffering from co-morbidity [9]. People with symptoms suggestive of LRTIs can contract tuberculosis (TB) and/or other bacterial and viral infections [10]. Over the years, the most severe cases of pneumonia have been associated with Mycobacterium tuberculosis, with little information on other relevant bacterial pathogens [11]. Some common pathogens causing LRTIs other than Mycobacterium tuberculosis include: Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae and Staphylococcus aureus [11].
The viral and bacterial etiologies of ARIs have been well documented in Northern Hemisphere countries [12,13]. However, few studies are available in Africa [14]. Thus, the present study aims to summarize the literature related to the etiology of respiratory infections in sub-Saharan African countries and to identify information gaps to improve essential knowledge on the subject.
We focused our research on sub-Saharan Africa, as epidemiological, socioeconomic and vaccine policy factors in North Africa would probably be very different [15]. Indeed, the distinction between North Africa and sub-Saharan Africa is climatically and ecologically significant because of the natural barrier created by the Sahara Desert, the world’s largest desert with a harsh, hot climate [16].

2. Methods

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was followed for our review [17]. This review was registered on the Open Science Framework; Registration DOI: https://doi.org/10.17605/OSF.IO/EXRCS (https//osf.io/nsd5m/, accessed on 29 July 2024).

2.1. Search Strategy

This review considers data from documents published online (articles, reports, etc.) that reported information on both viral and bacterial etiology of ARIs in sub-Saharan Africa, by searching the online bibliographic databases PubMed, HINARI and Google Scholar using the following key terms: “Acute respiratory infections”, “Upper respiratory infections”, “Lower respiratory infections”, “Viruses”, “Bacteria”, “Respiratory syndrome”, “Influenza syndrome”, “sub-Saharan Africa”, “Prevalence/Proportion”, and “etiology”. The reference list of selected articles was used as a lead for identifying further studies. The Boolean operators “AND” and “OR” were used to combine two or more terms. The search was limited to studies published in English or French, involving patients of any age in sub-Saharan Africa, in which pathogens were identified using immunofluorescence assays (IFA), Polymerase Chain Reactions (PCR), viral cultures, bacterial cultures, or a combination of these methods.
We also adopted the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist [17]. Two research questions guided this review: (1) What is the etiology of respiratory infections in sub-Saharan Africa, viral and/or bacterial? (2) What are the positive proportions of these pathogens in each study?

2.2. Study Selection

This review compiles studies focused on ARIs caused by viruses and/or bacteria. We only considered data from sub-Saharan Africa reported in papers published between 2010 and 2023, in English or French.

2.3. Inclusion Criteria

Studies included were cohort, analytical, prospective, retrospective, and cross-sectional investigations reporting the proportion of respiratory viruses and bacteria in hospital and/or community settings. In the case of repeated studies, where the same population was recruited and examined over the same period, only the most recent or most complete study was included.

2.4. Exclusion Criteria

There were no age or gender restrictions (Figure 1). Exclusion criteria were mainly: (i) respiratory infections of non-human origin; (ii) comparison of PCR kits for identification of respiratory pathogens; and (iii) studies on respiratory infection management policy. Endnote software version X9 Bld 12062, was used to remove duplicates and manage records during the screening process.

2.5. Data Extraction

Full versions of selected articles were downloaded and reviewed by two study authors. Data were extracted using a predefined form with the following information: (i) references; (ii) sample collection period; (iii) year of publication; (iv) study country; (v) age range; (vi) study objective; (vii) zone/sample size; (viii) study framework; (ix) type of sampling; (x) diagnostic methods; (xi) proportion of pathogens; and (xii) type of study.

2.6. Data Summary

We synthesized the data by summarizing the main findings of each study. Given the variety of study types included in the review, ranging from simple descriptive to analytical studies, we have considered a synthesis more appropriate rather than a formal meta-analysis. Tables were created to list all the pathogens found in each study, together with relevant study information as mentioned above on data extraction.

3. Results

3.1. Literature Review

The published articles included in this review were those from studies with samples collected from 2006 to 2022. To filter articles for this review, we initially identified a total of 2168 articles from PubMed, HINARI and Google Scholar that fit with our initial search strategy. Of these, 50 studies were included and 2125 were excluded, after screening each article (Figure 1).
Of the 50 studies included, 9 focused on viral and bacterial strains responsible for pneumonia in children and the elderly [18,19,20,21,22], and 41 focused on the surveillance and epidemiology of viral or bacterial strains responsible for respiratory infections. Among them, 36 studies were carried out in outpatients, whereas 14 studies were from hospitalized patients (Table 1 and Table 2). All viruses and bacteria found in hospitalized patients were also identified in outpatients.
Many of these studies were carried out among children under 5 years of age. Articles excluded were related to comparisons of amplification kits, respiratory infection management policy, data from countries other than Africa, and those concerning non-human respiratory infections.

3.2. Features of Included Studies

The 50 studies involved a total of 81,621 patients. Sample size ranged from 91 to 14,119 ARI patients per study. The included studies were conducted in 24 sub-Saharan African countries (Figure 2).
A total of 6 published studies were conducted in Cameroon; 4 in Ghana, Gabon and Burkina Faso; 3 each in the Democratic Republic of the Congo (DRC), Nigeria, Zambia and Kenya; 2 studies each in South Africa, Ivory Coast, Niger and Mali, respectively; and one study in each of the following countries: Senegal, Tanzania, Ethiopia, Central African Republic (CAR), Angola, Mozambique, Uganda, Togo, Namibia, Madagascar, Gambia and Sudan.
We identified 33 (66%) cross-sectional (descriptive and case–control) studies, 8 (16%) prospective or longitudinal studies, 6 (12%) retrospective studies, 2 (4%) cohort studies and 1 (2%) analytical study (Figure 3).
Considering settings in which these published studies were focused, there were 37 (74%) hospital-based studies, 11 (22%) community-based studies, and 2 (4%) were not indicated. The study setting was urban in 42 (84%) studies, and mixed (rural, semi-rural and pre-urban) in 8 (16%) studies.
Pathogens were identified in a variety of respiratory samples, including nasal swabs, oropharyngeal swabs, nasopharyngeal aspirates, induced sputum, tracheal aspirates, bronchoalveolar lavage swabs, urine, blood and pulmonary aspirates.
Respiratory viruses were detected using immunofluorescence tests, multiplex/simplex RT-PCR, conventional PCR, blood culture and viral cultures (Table 1). RT-PCR was the most frequently used diagnostic method. For the detection of individual bacteria, only bacterial cultures and PCR were performed.

3.3. Etiology of Pathogens Detected

All the respiratory pathogens identified in these studies were viral and bacterial (Table 1 and Table 2). Among 50 studies reviewed, human respiratory syncytial virus was the most frequently identified, with a proportion ranging from 0.6 to 59%, followed by human rhinovirus (7.5–73%), Influenza A/B virus (0.9–69.1%), human adenovirus (0.9–30.8%), human parainfluenza virus 1–4 (2–24%), enterovirus (2.9–25.5%), human coronaviruses (1.4–13.9%), human metapneumovirus (1–23.3%), SARS-CoV-2 (0.4–44%) and human bocavirus (1.4–16.2%) (Table 3).
Among the bacteria detected (Table 1 and Table 2), the most prevalent were Streptococcus pneumoniae (1–96%), followed by Haemophilus influenzae type b (2.5–54%), and Klebsiella pneumoniae (1.4–49.9%). Other bacterial species, notably Staphylococcus aureus (1.7–12.2%), Pseudomonas aeruginosa (1.4–37.5%), Mycobacterium tuberculosis (6.5%), Salmonella typhi (1.6%) and other very rarely identified bacteria, such as: M. catarrhalis (46.2%), B. Pertussis (0.1%), and Enterobacter sp. (22.2%) (Table 3).

4. Discussion

Respiratory infections constitute one of the major public health problems with an important socioeconomic impact [3,4]. Recently, SARS-CoV-2 infection, with clinical manifestations similar to those of common respiratory viruses, showed how often a respiratory infection may become pandemic and revealed the fragility of healthcare systems, particularly in sub-Saharan Africa [64]. Thus, knowledge of the etiology of respiratory pathogens is essential for better management of infections.
This review updates known information on respiratory infections of viral and/or bacterial etiology in sub-Saharan Africa over the last twelve years. The overall goal of this systematic review was to inform public health actors and researchers on the etiology of respiratory infections (viral and bacterial) in Africa and to provide information that can support actions to optimize decision-making by health authorities for the control of these infections.
A wide variety of detection techniques were found in this review, including molecular viral detection and bacterial culture, which is the universal and reference method for the characterization of respiratory infection pathogens. However, other tools such as neutrophil to lymphocyte ratio (NLR) have been recently successfully tested for an early differential diagnosis of pneumonia’s etiology in children in Egypt and Italy [65,66] and could be used in sub-Saharan Africa, mainly where financial resources are limited. As demonstrated in adults [67,68], NLR is a relevant diagnostic tool that reflects the imbalance between innate and adaptive immunity, and its recent pediatric application confirms its potential in the early identification of respiratory infectious causes. The results highlight a predominance of human respiratory syncytial virus and a strong association between human rhinovirus and Influenza A/B virus in children aged below 5 years, presenting with influenza-like illness. The other most frequently detected viruses were adenovirus and all four types of human Parainfluenza virus. This study also showed respiratory infections of bacterial origin, with the most frequently identified species being Streptococcus pneumoniae and Haemophilus influenzae, mainly in bacterial culture as well as in sputum and Brancoalveolar lavage (BAL) samples in adults. These findings may not globally reflect the real picture of different pathogens associated with respiratory infections. Thus, comparison with available WHO African Region reports is needed.
Little or no data were found on the etiology of respiratory infections in many sub-Saharan African countries. Of the 48 countries in sub-Saharan Africa (wikipedia.org/wiki/Afique_sub-saharienne, accessed on 28 September 2023), the 50 studies included in this review were carried out in only 24 countries, the majority of which were in Central and West Africa (Figure 2). No published studies were carried out in the Republic of the Congo, although it borders two (Cameroon and Democratic Republic of the Congo) of the five countries where the number of deaths from childhood pneumonia was the highest [69]. This lack of data could probably be due to the poor implementation of respiratory infection surveillance activities.
The pattern of predominance of human respiratory syncytial virus in this study is consistent with that reported by several previous systematic reviews [6,70,71,72]. Regardless of various factors, including screening test, type of sample tested, age of children, type of education, and severity of infection, most studies indicated that human respiratory syncytial virus is the predominant causative agent of cases of respiratory diseases such as bronchiolitis, asthma, and wheezing with an incidence of 50–80% [73]. Rhinovirus and Influenza A/B, the second most common viruses observed, have long been considered a cause of benign respiratory tract infections such as the common cold [14].
We found five studies that presented cases of viral and bacterial co-infections at rates of around 14% in our review [14,19,20,21,22]. Although Streptococcus pneumoniae is known to be more prevalent in superinfection in some respiratory syndromes, such as Influenza [74,75], Haemophilus influenzae and Klebsiella spp. were also identified mostly in co-infection. This observation correlates with the review by Lansbury et al., who also showed that Klebsiella pneumoniae and Haemophilus influenzae were among the most frequent co-infecting bacterial pathogens even in patients with COVID-19 [76,77]. Staphylococcus aureus was one of the least present, as expected [18]. Irrespective of testing issues, co-infection with other respiratory pathogens has important implications for diagnosis and prognosis.
Seasonality and study duration could clearly also lead to variability in the proportion of viruses/bacteria responsible for respiratory infections.

5. Conclusions

This review shows that a number of viruses are associated with ARIs in children and adults in sub-Saharan Africa. The WHO’s global strategy for the control of ARI in children under 5 years of age must rigorously consider the importance of both viral and bacterial cases. Moreover, the results highlight the lack of data for several sub-Saharan African countries. Further high-quality studies are needed to determine the role of viruses and bacteria in ARI. In this vein, an approach combining the scientific studies and institutional reports should be considered to provide adequate epidemiological and etiological information.

6. Study Limits

This study has several limitations: (1) Only publications in English or French were taken into account, excluding data published in Portuguese, which is the official language of five African countries (Angola, Cape Verde, Guinea-Bissau, Mozambique and São Tomé and Principe), and in Spanish, the official language of Equatorial Guinea. (2) The unpublished literature also constitutes an information bias in this systematic review. Finally, we did not assess the statistical quality of the studies by meta-analysis but included all articles that met the inclusion criteria. (3) Although the WHO reports are an essential source for global surveillance of respiratory infections, producing annual reports on regional or continental global health statistics [78], we have chosen to focus on more detailed scientific sources specific to our study context, with more detailed information on etiological specificity.

Author Contributions

J.E.D.L. and P.I.M. conceived and designed the study and initiated the manuscript; F.K.-K., P.B., E.M.L. and F.R.N. supervised the study. All authors have read and agreed to the published version of the manuscript.

Funding

This review is a prelude to the activities of the COPANFLU project funded by IRD as part of the “Jeunes Equipes Associées à l’IRD” program.

Acknowledgments

Many thanks to Donatien MOUKASSA, Segun Isaac OYEDEJI, Régis DOSSOU-YOVO, Léa G. NGANGOUE, Grâce FILA-FILA, Cynthia NKOUA ep. GOMA, Hosanna L. LENGUIYA, Henri OBA, Aldi Fred MANDIANGOU, Novy Charel BOBOUAKA, Dachel EYENET, Igor J. LOUZOLO, Matthieu Fritz, Valchy B. MIEGAKANDA, Wivine S. MOUELLET, Brel J. NGATALI SAYA, Ghislain DZERET, Lucette N. Macosso, Christelle BIKOUMOU, Max B. KIAMESSO, Vishnou R. AMPIRI, Yann MAVOUNGOU, Tarcisse BALOKI, Georcil AHOUET, Isaac Samuel ONYANKOUANG, Faly A. SOLOKA, Reiche Golmard ELENGA, Durel BABISSAT, Jordy Ahmed DONIAMA, Christ M. Stéphane VEMBE MAHOUNGA, Georges TSOUMOU-GOUENDE, Bertivie C. MATONGO, Fibland OKANDZE, Ines BAKOUMA, Princesse B. BANZOUZI, Laureate MADINGOU, Amour MOUANDA, Devane TSIAMBOULOU, Vardi AKOUALA, Divin NZILA, Placide J. MALOUONA, Eudes F. BOPOPO, Nhorica F. NGOMA, Emmanuel D. MAVOUNGOU, Mavie NGALOLI, Riche ENGAMBE, Narcis PIKEINE, Caleb MOUPASSA, Belle S. MOUKALA, Joyce E. LOUKANOU, Davel W. BATAMBIKA, Orphée O. LOUVILAT, Mondesir KOKO, Blaise MUAKA-MATALA, and Lesmiens T. KIMBATSA for their assistance with documentary research and reading of the manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Zhang, S.; Zhang, W.; Tang, Y.W. Molecular diagnosis of viral respiratory infections. Curr. Infect. Dis. Rep. 2011, 13, 149–158. [Google Scholar] [CrossRef]
  2. Obando-Pacheco, P.; Justicia-Grande, A.J.; Rivero-Calle, I.; Rodríguez-Tenreiro, C.; Sly, P.; Ramilo, O.; Mejías, A.; Baraldi, E.; Papadopoulos, N.; Nair, H.; et al. Respiratory syncytial virus seasonality: A global overview. J. Infect. Dis. 2018, 217, 1356–1364. [Google Scholar] [CrossRef] [PubMed]
  3. Jarju, S.; Greenhalgh, K.; Wathuo, M.; Banda, M.; Camara, B.; Mendy, S.; Sowe, G.; Dahaba, P.; Jammeh, L.; Bajinka, Y.; et al. Viral etiology, clinical features and antibiotic use in children <5 years of age in The Gambia presenting with influenza-like illness. Pediatr. Infect. Dis. J. 2020, 39, 925–930. [Google Scholar] [CrossRef] [PubMed]
  4. Bardsley, M.; Morbey, R.A.; Hughes, H.E.; Beck, C.R.; Watson, C.H.; Zhao, H.; Ellis, J.; Smith, G.; Elliot, A. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: A retrospective observational study. Lancet Infect. Dis. 2023, 23, 56–66. [Google Scholar] [CrossRef] [PubMed]
  5. Ouédraogo, S.; Traoré, B.; Nene Bi, Z.A.B.; Yonli, F.T.; Kima, D.; Bonané, P.; Congo, L.; Ouédraogo Traoré, R.; Yé, D.; Marguet, C.; et al. Viral etiology of respiratory tract infections in children at the pediatric hospital in Ouagadougou (Burkina Faso). PLoS ONE 2014, 9, e110435. [Google Scholar] [CrossRef]
  6. Sanou, A.M.; Cissé, A.; Millogo, T.; Sagna, T.; Tialla, D.; Williams, T.; Nzussouo, T.; Tarnagda, Z. Systematic review of articles on etiologies of acute respiratory infections in children aged less than five years in sub-Saharan Africa, 2000–2015. EC Microbiol. 2016, 6, 556–571. [Google Scholar]
  7. Sonego, M.; Pellegrin, M.C.; Becker, G.; Lazzerini, M. Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: A systematic review and meta-analysis of observational studies. PLoS ONE 2015, 10, e0116380. [Google Scholar] [CrossRef]
  8. Gadsby, N.J.; McHugh, M.P.; Russell, C.D.; Mark, H.; Morris, A.C.; Laurenson, I.F.; Hill, A.T.; Templeton, K.E. Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections. Clin. Microbiol. Infect. 2015, 21, 788.e1–788.e13. [Google Scholar] [CrossRef]
  9. Ayar, G.; Sahin, S.; Yazici, M.U.; Parlakay, A.Ö.; Tezer, H. RSV pneumonia in the pediatric intensive care unit. J. Pediatr. Inf. 2014, 8, 12–17. [Google Scholar] [CrossRef]
  10. Dube, F.S.; Kaba, M.; Robberts, F.J.; Ah Tow, L.; Lubbe, S.; Zar, H.J.; Nicol, M.P. Respiratory microbes present in the nasopharynx of children hospitalized with suspected pulmonary tuberculosis in Cape Town, South Africa. BMC Infect. Dis. 2016, 16, 597. [Google Scholar] [CrossRef]
  11. Deberu, O.; Nkrumah, B.; Sylverken, A.A.; Sambian, D.; Acheampong, G.; Amuasi, J.; Stebleson, A.; Agboyie, D.; Yenbaree, M.; Mensah, S.; et al. Common bacteria in sputum or gastric lavage of patients presenting with signs and symptoms of lower respiratory tract infections. Pan Afr. Med. J. 2021, 38, 383. [Google Scholar] [CrossRef] [PubMed]
  12. Yassine, H.M.; Sohail, M.U.; Younes, N.; Nasrallah, G.K. Systematic Review of the Respiratory Syncytial Virus (RSV) Prevalence, Genotype Distribution, and Seasonality in Children from the Middle East and North Africa (MENA) Region. Microorganisms 2020, 8, 713. [Google Scholar] [CrossRef] [PubMed]
  13. Haddad-Boubaker, S.; Mefteh, K.; Mejri, C.; Bouaffsoun, A.; El Moussi, A.; Boutiba, I.; Mnuf, K.; Slim, A.; Kechrid, A.; Smaoui, H. High genotypic diversity of Rhinoviruses obtained from Tunisian children with severe acute respiratory infection. J. Infect. Dev. Ctries. 2021, 15, 726–735. [Google Scholar] [CrossRef] [PubMed]
  14. Lagare, A.; Maïnassara, H.B.; Issaka, B.; Sidiki, A.; Tempia, S. Viral and bacterial etiology of severe acute respiratory illness among children <5 years of age without influenza in Niger. BMC Infect. Dis. 2015, 15, 515. [Google Scholar] [CrossRef]
  15. Gessner, B.D.; Shindo, N.; Briand, S. Seasonal influenza epidemiology in sub-Saharan Africa: A systematic review. Lancet Infect. Dis. 2011, 11, 223–235. [Google Scholar] [CrossRef]
  16. Wikipédia, L’encyclopédie Libre. Afrique. Available online: http://fr.wikipedia.org/w/index.php?title=Afrique&oldid=207325236 (accessed on 28 August 2023).
  17. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
  18. Tchatchouang, S.; Nzouankeu, A.; Kenmoe, S.; Ngando, L.; Penlap, V.; Fonkoua, M.C.; Pefura-Yone, E.; Njouom, R. Bacterial aetiologies of lower respiratory tract infections among adults in Yaoundé, Cameroon. BioMed Res. Int. 2019, 2019, 4834396. [Google Scholar] [CrossRef]
  19. Lagare, A.; Ousmane, S.; Dano, I.D.; Issaka, B.; Issa, I.; Mainassara, H.B.; Testa, J.; Tempia, S.; Mamadou, S. Molecular detection of respiratory pathogens among children aged younger than 5 years hospitalized with febrile acute respiratory infections: A prospective hospital-based observational study in Niamey, Niger. Health Sci. Rep. 2019, 2, e137. [Google Scholar] [CrossRef]
  20. Birindwa, A.M.; Kasereka, J.K.; Gonzales-Siles, L.; Geravandi, S.; Mwilo, M.; Tudiakwile, L.K.; Mwinja, N.; Muhigirwa, B.; Kashosi, T.; Manegabe, J.; et al. Bacteria and viruses in the upper respiratory tract of Congolese children with radiologically confirmed pneumonia. BMC Infect. Dis. 2021, 21, 837. [Google Scholar] [CrossRef]
  21. Mhimbira, F.; Hiza, H.; Mbuba, E.; Hella, J.; Kamwela, L.; Sasamalo, M.; Ticlla, T.; Said, K.; Mhalu, G.; Chiryamkubi, M.; et al. Prevalence and clinical significance of respiratory viruses and bacteria detected in tuberculosis patients compared to household contact controls in Tanzania: A cohort study. Clin. Microbiol. Infect. 2018, 25, 107.e1–107.e7. [Google Scholar] [CrossRef]
  22. Razanajatovo, N.H.; Guillebaud, J.; Harimanana, A.; Rajatonirina, S.; Ratsima, E.H.; Andrianirina, Z.Z.; Rakotoariniaina, H.; Andriatahina, T.; Orelle, A.; Ratovoson, R.; et al. Epidemiology of severe acute respiratory infections from hospital-based surveillance in Madagascar, November 2010 to July 2013. PLoS ONE 2018, 13, e0205124. [Google Scholar] [CrossRef]
  23. Lekana-Douki, S.E.; Mouinga-Ondémé, A.; Nkoghe, D.; Drosten, C.; Drexler, J.F.; Kazanji, M.; Leroy, E.M. Early introduction and delayed dissemination of pandemic influenza, Gabon. Emerg. Infect. Dis. 2013, 19, 644–647. [Google Scholar] [CrossRef]
  24. Lekana-Douki, S.E.; Nkoghe, D.; Drosten, C.; Ngoungou, E.B.; Drexler, J.F.; Leroy, E.M. Viral etiology and seasonality of influenza-like illness in Gabon, March 2010 to June 2011. BMC Infect. Dis. 2014, 14, 373. [Google Scholar] [CrossRef]
  25. Breiman, R.F.; Cosmas, L.; Njenga, M.K.; Williamson, J.; Mott, J.A.; Katz, M.A.; Erdman, D.; Schneider, E.; Oberste, M.S.; Neatherlin, J.; et al. Severe acute respiratory infection in children in a densely populated urban slum in Kenya, 2007–2011. BMC Infect. Dis. 2015, 15, 95. [Google Scholar] [CrossRef]
  26. Bobossi Serengbe, G.; Gody, J.C.; Fioboy, R.; Nakoune, E. Étiologie virale des infections respiratoires aiguës de l’enfant à Bangui. Arch. Pediatr. 2015, 22, 324–325. [Google Scholar] [CrossRef]
  27. Kenmoe, S.; Tchendjou, P.; Vernet, M.A.; Moyo-Tetang, S.; Mossus, T.; Njankouo-Ripa, M.; Kenne, A.; Beng, V.P.; Vabret, A.; Njouom, R. Viral etiology of severe acute respiratory infections in hospitalized children in Cameroon, 2011–2013. Influenza Other Respir. Viruses 2016, 10, 386–393. [Google Scholar] [CrossRef] [PubMed]
  28. Uzoamaka, M.; Ngozi, O.; Johnbull, O.S.; Martin, O. Bacterial etiology of lower respiratory tract infections and their antimicrobial susceptibility. Am. J. Med. Sci. 2017, 354, 471–475. [Google Scholar] [CrossRef] [PubMed]
  29. Niang, M.N.; Diop, N.S.; Fall, A.; Kiori, D.E.; Sarr, F.D.; Sy, S.; Goudiaby, D.; Barry, M.A.; Fall, M.; Dia, N. Respiratory viruses in patients with influenza-like illness in Senegal: Focus on human respiratory adenoviruses. PLoS ONE 2017, 12, e0174287. [Google Scholar] [CrossRef] [PubMed]
  30. Famoroti, T.; Sibanda, W.; Ndung’u, T. Prevalence and seasonality of common viral respiratory pathogens, including Cytomegalovirus in children, between 0–5 years of age in KwaZulu-Natal, an HIV endemic province in South Africa. BMC Pediatr. 2018, 18, 240. [Google Scholar] [CrossRef]
  31. Kadjo, H.A.; Adjogoua, E.; Dia, N.; Adagba, M.; Abdoulaye, O.; Daniel, S.; Kouakou, B.; Ngolo, D.C.; Coulibaly, D.; Ndahwouh, T.N.; et al. Detection of non-influenza viruses in acute respiratory infections in children under five-year-old in Cote d’Ivoire (January–December 2013). Afr. J. Infect. Dis. 2018, 12, 78–88. [Google Scholar] [CrossRef]
  32. Sanou, A.M.; Wandaogo, S.C.M.; Poda, A.; Tamini, L.; Kyere, A.E.; Sagna, T.; Ouedraogo, M.S.; Pauly, M.; Hübschen, J.M.; Muller, C.P.; et al. Epidemiology and molecular characterization of influenza viruses in Burkina Faso, sub-Saharan Africa. Influenza Other Respir. Viruses 2018, 12, 490–496. [Google Scholar] [CrossRef]
  33. Obodai, E.; Odoom, J.K.; Adiku, T.; Goka, B.; Wolff, T.; Biere, B.; Schweiger, B.; Reiche, J. The significance of human respiratory syncytial virus (HRSV) in children from Ghana with acute lower respiratory tract infection: A molecular epidemiological analysis, 2006 and 2013–2014. PLoS ONE 2018, 13, e0203788. [Google Scholar] [CrossRef]
  34. Lekana-Douki, S.E.; Behillil, S.; Enouf, V.; Leroy, E.M.; Berthet, N. Detection of human bocavirus-1 in both nasal and stool specimens from children under 5 years old with influenza-like illnesses or diarrhea in Gabon. BMC Res. Notes 2018, 11, 495. [Google Scholar] [CrossRef] [PubMed]
  35. Kabego, L.; Balol’Ebwami, S.; Kasengi, J.B.; Miyanga, S.; Bahati, Y.L.; Kambale, R.; de Beer, C. Human respiratory syncytial virus: Proportion, viral co-infections and risk factors for lower respiratory tract infections in children under 5 years of age at a general hospital in the Democratic Republic of Congo. J. Med. Microbiol. 2018, 67, 514–522. [Google Scholar] [CrossRef] [PubMed]
  36. Kenmoe, S.; Vernet, M.A.; Le Goff, J.; Penlap, V.B.; Vabret, A.; Njouom, R. Molecular characterization of human adenovirus associated with acute respiratory infections in Cameroon from 2011 to 2014. Virol. J. 2018, 15, 153. [Google Scholar] [CrossRef] [PubMed]
  37. Adema, I.W.; Kamau, E.; Nyiro, J.U.; Otieno, G.P.; Lewa, C.; Munywoki, P.K.; Nokes, D.J. Surveillance of respiratory viruses among children attending a primary school in rural coastal Kenya. Wellcome Open Res. 2020, 5, 63. [Google Scholar] [CrossRef]
  38. Buchwald, A.G.; Tamboura, B.; Tennant, S.M.; Haidara, F.C.; Coulibaly, F.; Doumbia, M.; Diallo, F.; Keita, A.M.; Sow, S.O.; Kotloff, K.L.; et al. Epidemiology, risk factors, and outcomes of respiratory syncytial virus infections in newborns in Bamako, Mali. Clin. Infect. Dis. 2020, 70, 59–66. [Google Scholar] [CrossRef]
  39. Obe, O.A.; Mutiu, B.W.; Amoo, A. Respiratory Syncytial Virus Infection among Children in Lagos, Nigeria. J. Clin. Immunol. Microbiol. 2021, 2, 1–11. [Google Scholar] [CrossRef]
  40. Kouakou, V.; Kadjo, H.; Oulo, N.A.; N’guessan, F.D.; N’Douba, A. Surveillance of Respiratory Syncytial Virus in Children Aged 0–5 years in Côte d’Ivoire. Am. J. BioScience 2021, 9, 185. [Google Scholar] [CrossRef]
  41. Kenmoe, S.; Sadeuh-Mba, S.A.; Vernet, M.A.; Beng, V.P.; Vabret, A.; Njouom, R. Molecular epidemiology of Enteroviruses and Rhinoviruses in patients with acute respiratory infections in Yaounde, Cameroon. Influenza Other Respir. Viruses 2021, 15, 641–650. [Google Scholar] [CrossRef]
  42. Ntagereka, P.B.; Basengere, R.A.; Baharanyi, T.C.; Kashosi, T.M.; Buhendwa, J.-P.C.; Bisimwa, P.B.; Kusinza, A.B.; Mugumaarhahama, Y.; Shukuru, D.W.; Patrick, S.B.; et al. Molecular evidence of coinfection with acute respiratory viruses and high proportion of SARS-CoV-2 among patients presenting flu-like illness in Bukavu city, Democratic Republic of Congo. Can. J. Infect. Dis. Med. Microbiol. 2022, 2022, 1553266. [Google Scholar] [CrossRef]
  43. Kafintu-Kwashie, A.A.; Nii-Trebi, N.I.; Obodai, E.; Neizer, M.; Adiku, T.K.; Odoom, J.K. Molecular epidemiological surveillance of viral agents of acute lower respiratory tract infections in children in Accra, Ghana. BMC Pediatr. 2022, 22, 364. [Google Scholar] [CrossRef]
  44. Kolawole, O.; Oguntoye, M.; Dam, T.; Chunara, R. Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria. BMC Res. Notes 2017, 10, 712. [Google Scholar] [CrossRef]
  45. Ukuli, Q.A.; Erima, B.; Mubiru, A.; Atim, G.; Tugume, T.; Kibuuka, H.; Mworozi, E.; Ducatez, M.F.; Wabwire-Mangen, F.; Byarugaba, D.K. Molecular characterisation of human adenoviruses associated with respiratory infections in Uganda. BMC Infect. Dis. 2023, 23, 435. [Google Scholar] [CrossRef] [PubMed]
  46. Feikin, D.R.; Njenga, M.K.; Bigogo, G.; Aura, B.; Aol, G.; Audi, A.; Jagero, G.; Muluare, P.O.; Gikunju, S.; Nderitu, L.; et al. Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007–2010. PLoS ONE 2012, 7, e43656. [Google Scholar] [CrossRef] [PubMed]
  47. Fokam, J.; Takou, D.; Nka, A.D.; Ka’e, A.C.; Yagai, B.; Chenwi, C.A.; Semengue, E.N.J.; Beloumou, G.A.; Ndjeyep, S.C.D.; Abba, A.; et al. Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000. J. Public Health Afr. 2022, 13, 2142. [Google Scholar] [CrossRef] [PubMed]
  48. Dorkenoo, A.M.; Gbeasor-Komlanvi, F.A.; Gbada, K.; Zida-Compaore, W.I.C.; Teou, D.; Konu, Y.R.; Lack, F.; Sadio, A.J.; Tchankoni, M.K.; Dagnra, A.C.; et al. Prevalence of malaria and COVID-19 in febrile patients in Lomé, Togo in 2020. Acta Parasitol. 2022, 67, 1335–1342. [Google Scholar] [CrossRef] [PubMed]
  49. Alber, D.; Haidara, F.C.; Luoma, J.; Adubra, L.; Ashorn, P.; Ashorn, U.; Badji, H.; Cloutman-Green, E.; Diallo, F.; Ihamuotila, R.; et al. SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: An observational study 2020–2021. BMJ Open 2022, 12, e060367. [Google Scholar] [CrossRef]
  50. Khairy, A.; Elhussein, N.; Elbadri, O.; Mohamed, S.; Malik, E.M. Epidemiology of COVID-19 among Children and Adolescents in Sudan 2020–2021. Epidemiologia 2023, 4, 247–254. [Google Scholar] [CrossRef]
  51. Mulenga, L.B.; Hines, J.Z.; Fwoloshi, S.; Chirwa, L.; Siwingwa, M.; Yingst, S.; Wolkon, A.; Barradas, D.T.; Favaloro, J.; Zulu, J.E.; et al. Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: A cross-sectional cluster sample survey. Lancet Glob. Health 2021, 9, e773–e781. [Google Scholar] [CrossRef]
  52. Wadilo, F.; Feleke, A.; Gebre, M.; Mihret, W.; Seyoum, T.; Melaku, K.; Howe, R.; Mulu, A.; Mihret, A. Viral etiologies of lower respiratory tract infections in children <5 years of age in Addis Ababa, Ethiopia: A prospective case–control study. Virol. J. 2023, 20, 163. [Google Scholar]
  53. Baillie, V.L.; Moore, D.P.; Mathunjwa, A.; Baggett, H.C.; Brooks, A.; Feikin, D.R.; Hammitt, L.L.; Howie, S.R.; Knoll, M.D.; Kotloff, K.L.; et al. Epidemiology of the rhinovirus (RV) in African and Southeast Asian children: A case-control pneumonia etiology study. Viruses 2021, 13, 1249. [Google Scholar] [CrossRef]
  54. Simusika, P.; Bateman, A.C.; Theo, A.; Kwenda, G.; Mfula, C.; Chentulo, E.; Monze, M. Identification of viral and bacterial pathogens from hospitalized children with severe acute respiratory illness in Lusaka, Zambia, 2011–2012: A cross-sectional study. BMC Infect. Dis. 2015, 15, 52. [Google Scholar] [CrossRef] [PubMed]
  55. Loevinsohn, G.; Hardick, J.; Sinywimaanzi, P.; Fenstermacher, K.Z.J.; Shaw-Saliba, K.; Monze, M.; Gaydos, C.A.; Rothman, R.E.; Pekosz, A.; Thuma, P.E.; et al. Respiratory pathogen diversity and co-infections in rural Zambia. Int. J. Infect. Dis. 2021, 102, 291–298. [Google Scholar] [CrossRef] [PubMed]
  56. Yugbaré, S.O.O.; Ouédraogo, R.; Nenebi, A.; Traoré, B.; Congo, L.; Yonli, F.; Kima, D.; Bonané, P.; Yé, D.; Plantier, J.C.; et al. Infections à virus respiratoire syncytial (VRS) au CHU pédiatrique Charles de Gaulle de Ouagadougou, Burkina Faso. Bull. Soc. Pathol. Exot. 2016, 109, 20–25. [Google Scholar] [CrossRef] [PubMed]
  57. Kenmoe, S. Prévalence et Diversité Génétique des Virus Respiratoires au Cameroun. 2017. Available online: http://www.theses.fr/2017NORMC417/document (accessed on 9 September 2025).
  58. Sanou, A.M. Epidemiology and Molecular Characterization of Viruses and Bacteria Detected in Acute Respiratory Infections in Children under Five in Burkina Faso. Master’s Thesis, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso, 2018. Available online: https://bibliovirtuelle.u-naziboni.bf/biblio/opac_css/docnume/UFR-SJPEG/IDR-2018-SAN-EPI.pdf (accessed on 13 December 2017).
  59. O’Callaghan-Gordo, C.; Bassat, Q.; Morais, L.; Díez-Padrisa, N.; Machevo, S.; Nhampossa, T.; Nhalungo, D.; Sanz, S.; Quintó, L.; Alonso, P.L.; et al. Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: A malaria endemic area with high prevalence of human immunodeficiency virus. Pediatr. Infect. Dis. J. 2011, 30, 39–44. [Google Scholar] [CrossRef]
  60. Jones, A.H.; Ampofo, W.; Akuffo, R.; Doman, B.; Duplessis, C.; Amankwa, J.A.; Sarpong, C.; Sagoe, K.; Agbenohevi, P.; Puplampu, N.; et al. Sentinel surveillance for influenza among severe acute respiratory infection and acute febrile illness inpatients at three hospitals in Ghana. Influenza Other Respir. Viruses 2016, 10, 367–374. [Google Scholar] [CrossRef]
  61. Simeon, P.; Godman, B.; Kalemeera, F. Antibiotics’ susceptibility patterns of bacterial isolates causing lower respiratory tract infections in ICU patients at referral hospitals in Namibia. Hosp. Pract. 2021, 49, 356–363. [Google Scholar] [CrossRef]
  62. Nzoghe, A.M.; Padzys, G.S.; Siawaya, A.C.M.; Yattara, M.K.; Leboueny, M.; Houechenou, R.M.A.; Bongho, E.C.; Mba-Mezemze, C.; Ndjindji, O.M.; Biteghe-Bi-Essone, J.C.; et al. Dynamic and features of SARS-CoV-2 infection in Gabon. Sci. Rep. 2021, 11, 9672. [Google Scholar]
  63. Sebastião, C.S.; Parimbelli, P.; Mendes, M.; Sacomboio, E.; Morais, J.; de Vasconcelos, J.N.; Brito, M. Prevalence and Risk Factors of SARS-CoV-2 Infection among Parturients and Newborns from Luanda, Angola. Pathogens 2021, 10, 1494. [Google Scholar] [CrossRef]
  64. Anjorin, A.A.; Abioye, A.I.; Asowata, O.E.; Soipe, A.; Kazeem, M.I.; Adesanya, I.O.; Raji, M.A.; Adesanya, M.; Oke, F.A.; Lawal, F.J.; et al. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop. Med. Int. Health 2021, 26, 2–13. [Google Scholar] [CrossRef]
  65. Omran, A.; Awad, H.; Ibrahim, M.; El-Sharkawy, S.; Elfiky, S.; Rezk, A.R. Lung Ultrasound and Neutrophil Lymphocyte Ratio in Early Diagnosis and Differentiation between Viral and Bacterial Pneumonia in Young Children. Children 2022, 9, 1457. [Google Scholar] [CrossRef]
  66. Buonacera, A.; Stancanelli, B.; Colaci, M.; Malatino, L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int. J. Mol. Sci 2022, 23, 3636. [Google Scholar] [CrossRef]
  67. de Jager, C.P.; Wever, P.C.; Gemen, E.F.; Kusters, R.; van Gageldonk-Lafeber, A.B.; van der Poll, T.; Laheij, R.J. The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia. PLoS ONE 2012, 7, e46561. [Google Scholar] [CrossRef]
  68. Cataudella, E.; Giraffa, C.M.; Di Marca, S.; Pulvirenti, A.; Alaimo, S.; Pisano, M.; Terranova, V.; Corriere, T.; Ronsisvalle, M.L.; Di Quattro, R.; et al. Neutrophil-To-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia. J. Am. Geriatr. Soc. 2017, 65, 1796–1801. [Google Scholar] [CrossRef] [PubMed]
  69. Nair, H.; Simões, E.A.; Rudan, I.; Gessner, B.D.; Azziz-Baumgartner, E.; Zhang, J.S.F.; Feikin, D.R.; Mackenzie, G.A.; Moiïsi, J.C.; Roca, A.; et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: A systematic analysis. Lancet 2013, 381, 1380–1390. [Google Scholar] [CrossRef] [PubMed]
  70. Naz, R.; Gul, A.; Javed, U.; Urooj, A.; Amin, S.; Fatima, Z. Etiology of acute viral respiratory infections common in Pakistan: A review. Rev. Med. Virol. 2019, 29, e2024. [Google Scholar] [CrossRef] [PubMed]
  71. Borchers, A.T.; Chang, C.; Gershwin, M.E.; Gershwin, L.J. Respiratory syncytial virus—A comprehensive review. Clin. Rev. Allergy Immunol. 2013, 45, 331–379. [Google Scholar] [CrossRef]
  72. Zhang, N.; Wang, L.; Deng, X.; Liang, R.; Su, M.; He, C.; Hu, L.; Su, Y.; Ren, J.; Yu, F.; et al. Recent advances in the detection of respiratory virus infection in humans. J. Med. Virol. 2020, 92, 408–417. [Google Scholar] [CrossRef]
  73. Van der Zalm, M.M.; Uiterwaal, C.S.; Wilbrink, B.; Koopman, M.; Verheij, T.J.; van der Ent, C.K. The influence of neonatal lung function on rhinovirus-associated wheeze. Am. J. Respir. Crit. Care Med. 2011, 183, 262–267. [Google Scholar] [CrossRef]
  74. Zhu, X.; Ge, Y.; Wu, T.; Zhao, K.; Chen, Y.; Wu, B.; Zhu, F.; Zhu, B.; Cui, L. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020, 285, 198005. [Google Scholar] [CrossRef]
  75. Musuuza, J.S.; Watson, L.; Parmasad, V.; Putman-Buehler, N.; Christensen, L.; Safdar, N. Proportion and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS ONE 2021, 16, e0251170. [Google Scholar] [CrossRef]
  76. Lansbury, L.; Lim, B.; Baskaran, V.; Lim, W.S. Co-infections in people with COVID-19: A systematic review and meta-analysis. J. Infect. 2020, 81, 266–275. [Google Scholar] [CrossRef]
  77. Davis, B.; Rothrock, A.N.; Swetland, S.; Andris, H.; Davis, P.; Rothrock, S.G. Viral and atypical respiratory co-infections in COVID-19: A systematic review and meta-analysis. J. Am. Coll. Emerg. Physicians Open 2020, 1, 533–548. [Google Scholar] [CrossRef]
  78. World Health Organization (WHO). World Health Statistics. Available online: https://www.who.int/data/gho/publications/world-health-statistics (accessed on 3 October 2023).
Children 12 01212 g001
Figure 1. Summary of search strategy (PRISMA flow diagram).
Figure 1. Summary of search strategy (PRISMA flow diagram).
Children 12 01212 g001
Children 12 01212 g002
Figure 2. Geographical identification of the 50 included studies associated with the 24 countries (map generating with QGIS 3.16.0).
Figure 2. Geographical identification of the 50 included studies associated with the 24 countries (map generating with QGIS 3.16.0).
Children 12 01212 g002
Children 12 01212 g003
Figure 3. Distribution of different types of studies.
Figure 3. Distribution of different types of studies.
Children 12 01212 g003
Table 1. Summary of published studies carried out in outpatients.
Table 1. Summary of published studies carried out in outpatients.
ReferencesCollection PeriodYear of PublicationStudy CountryAge RangeStudy ObjectiveZone/Sample SizeStudy FrameworkType of SamplingDiagnostic MethodsProportion of PathogensType of Study
Lekana
-Douki et al. [23]		2009–20112013GabonNo limitTo report the results of a large surveillance study for pH1N1 in Gabon during a 2-year period, July 2009–June 2011Urban/966Health care centers
The regional hospitals		NasalRT-PCRFlu A (61%); Flu B (39%)Cross-sectional/Prospective
Lekana-
Douki et al. [24]		2010–20112014GabonNo limitTo determine the prevalence, etiology and seasonality of viral respiratory tract infections(Urban)/1041Health care centers
The regional hospitals		NasopharyngealOne-step multiplex real-time RT-PCRHAdV (17.5%), HPIV 1–4 (16.8%), EV (14.7%), HRSV (13.5%), and Flu A (11.9%)Cross-sectional
Ouédraogo
et al. [5]		2010–20112014Burkina Faso<3 yearsTo identify the respiratory viruses, present in children admitted to or consulting
at the pediatric hospital in Ouagadougou		(Urban)/209Charles de Gaulle pediatric hospitalNasopharyngealOne-step multiplex real-time RT-PCRHRV (59.1%); EV (25.5%); HRSV (16.1%); HMPV (9.4%)Prospective
Breiman
et al. [25]		2007–20112015Kenya<5 yearsTo analyze data from our population-based infectious disease surveillance (PBIDS)
site in Kibera, an
urban slum in Nairobi		2592Community
(Households)		Blood
Naso/Oro-pharyngeal		Hemoculture
RT-qPCR		HRV/EV (42%); HRSV (25%); HAdV (20%); HMPV (13.7%), Flu A (10.8%); Salmonella typhi (1.6%); Streptococcus pneumoniae (1%); Staphylococcus aureus (1.7%)Cross-sectional
Serenbe
et al. [26]		20132015Central African Republic<5 yearsTo determine the contribution of viruses to respiratory infections in children under five.361Referral hospital
Outlying pediatric centers		NasopharyngealRT-qPCR
Multiplex RT-PCR		HRV (47.5%); FluA/B (26.6%); HPIV-3(9.3%); HRSV (5.8%); EV (4.3%); HAdV (2.9%); HBoV (1.4%); HCoV (1.4%)Cross-sectional
Kenmoe
et al. [27]		2011–20132016Cameroon≤15To investigate the viral etiology and seasonality of
SARI in hospitalized children in Yaoundé, Cameroon		(Urban)/347Hospital (pediatric service)NasopharyngealMultiplex PCR
RT-PCR		HRSV (13.2%), HAdV (27.3%), HboV (10.6%), Flu A/B (9.8%); HPIV (6.6%); HCoV (5.7%); HMPV (2.3%); HRV/EV (11.5%)Prospective
Uzoamaka
et al. [28]		2014–20162017NigeriaNo limitTo determine the current trends of bacterial etiology of LRTIs among the patients that attended the University of Nigeria Teaching Hospital (UNTH), and their antimicrobial susceptibility profile with special interest in pan drug resistance(Peri-urban)
/954		HospitalExpectorationCulture
(MacConkey agar, blood agar, chocolate agar)		Klebsiella pneumonia (49.9%); Klebsiella spp./Pseudomonas aeruginosa, (1.4%)Cross-sectional
Niang et al. [29]2012–20152017SenegalNo limitTo investigate the epidemiologic and viral molecular features of
HAdVs circulating in Senegal after 4 consecutive years of sentinel surveillance of influenza like illness cases		(Urban)
/6381		HospitalNaso/Oro-pharyngealTwo-step multiplex real-time RT-PCRHAdV (30.8%); FluA/B (53.1%); HRV (30%); Ev (18.5%); HRSV (13.5%)Cross-sectional/
Prospective
Famoroti
et al. [30]		2011–20152018South Africa0–5 yearsTo determine the most common viral pathogens associated with ARTI among children between 0 and 5 years of age in KwaZulu-Natal(Urban)
/2172		Hospital (pediatric service)Expectoration
/Nasopharyngeal		Multiplex PCRHRSV (32.1%), HAdV (21.8%), HRV (15.4%), FluA swl (5.1%)Retrospective
Kadjo et al. [31]20132018Ivory Coast<5 yearsTo describe the epidemiological, clinical, and virological pattern of ARI that tested negative for influenza virus, in children under five years old(Urban)
/1340		Hospital (pediatric service)NasopharyngealRT-PCRHRV (31.92%), HRSV (24.4%), HPIV (20.5%), HCoV 229E (12.05%)Cross-sectional
Sanou et al. [32]2014–20152018Burkina Faso<5 yearsTo assess the prevalence and seasonal occurrence of influenza viruses in children with ILI and severe acute respiratory infection (SARI)(Urban)
/924		Healthcare centersNasopharyngealRT-PCRFlu A/B (15.1%), A(H3N2) (69.1%) A(H1N1) pdm09 (30.9%)Cross-sectional
Obodai et al. [33]2006, 2013–20142018Ghana<5 yearsTo assess HRSV diagnostics and/or surveillance in affected age groups in the future and to the molecular understanding of the HRSV circulation in Ghana, Africa(Urban)
/552		Hospital (pediatric service)NasopharyngealRT-PCRHRSV (23%)Cross-sectional
Lekana-Douki
et al. [34]		20182018Gabon<5 yearsTo evaluate the prevalence and the HBoV genotype in children under 5 years old with ILI or diarrhea in Gabon(Urban)
/810		Health
centers		NasopharyngealRT-PCRHBoV (4.4%)Retrospective
Kabego
et al. [35]		20162018Democratic Republic of the Congo<5 yearsTo determine the prevalence of human respiratory syncytial virus (HRSV) acute respiratory infection (ARI) in children under the age of 5 years at the Provincial General Hospital of Bukavu (PGHB), and to analyze factors associated with the risk of ARI being diagnosed as lower respiratory tract infection (LRTI)(Urban)
/146		General
Hospital		NasopharyngealMultiplex RT-PCRHRSV (21.2%); HRV (16.4%); HPIV-3 (16.6%) and HAdV (4.79%).Cross-sectional, analytical/Prospective
Mhimbira
et al. [21]		2013–20152018TanzaniaNo limitTo describe the prevalence of respiratory pathogens in TB patients and household contact controls, and the clinical significance of respiratory pathogens in TB patients(Urban)
/972		Community
(Households)		NasopharyngealMultiplex RT-PCRHRV (9.3%); Influenza A (3.1%); HRSV A (1.9%); H. influenzae (26.1%); S. pneumoniae (21.5%)Prospective cohort
Kenmoe
et al. [36]		2011–20142018Cameroon<15 yearsTo document the different types of HAdV circulating in Cameroon in children with acute respiratory infections(Urban)
/811		Hospital (pediatric service)NasopharyngealRT-PCRHAdV (27.12%)Cross-sectional
Razanajatovo et al. [22]2010–20132018MadagascarNo limitTo identify etiologies and describe clinical features of SARI-associated hospitalization in Madagascar(Urban)
/876		Hospital-
based		Nasopharyngeal,
Expectorations
Blood		Multiplex RT-PCR
Cytobacteriologic testing		HRSV (37.7%); FluA (18.4%); HRV (13.5%; HAdV (8.3%); S. Pneumoniae (50.3%); H. Influenzae b (21.4%); Klebsiella (4.6%)Prospective
Tchatchouang
et al. [18]		20192019CameroonNo limitTo identify the respiratory bacteria
of patients presenting with symptoms and clinical signs of LRTI at a referral center for respiratory diseases in Yaoundé, Cameroon		(Urban)
/141		Hospital
(Pneumology department)		Branco-alveolar lavage (BAV)Bacterial CultureS. pneumoniae/H. infuenzae (14.2%); K. pneumoniae (9.2%); S. aureus, (7.1%)Prospective
Adema
et al. [37]		2017–20182020Kenya<20 yearsTo advance understanding of the nature of spread of respiratory viruses(Urban)
/781		Community (School)NasopharyngealMultiplex RT-PCRHRV (16.7%); HPIV (2.7%); HCoV (229E, NL63, OC43) (2.0%); HAdV (0.9%); HRSV (0.6%)Longitudinal/
Cohort
Jarju et al. [3]2018–20192020Gambia<5 yearsTo determine the viral etiology, seasonality, clinical features and associated AMU(Urban)
/805		Hospital
(Medical Research Council Unit)		NasopharyngealMultiplex RT-PCRHRV (36.7%); Flu A (7.0%); Flu B (1.4%); HRSV (14.7%); HMPV (7.2%); HPIV (13.2%); HCoV (229E, OC43 or NL63) (7.8%)Prospective
Buchwald
et al. [38]		2011–20132020Mali<2 yearsTo provide the first estimates of RSV incidence in Mali(Urban)
/1333		Community (Households)Naso/Oro-pharyngealRT-PCRHRSV (37%)Cohort
Obe et al. [39]20212021Nigeria<5 yearsTo determine molecular prevalence of RSV among under five children admitted with ALRTTIs in a tertiary hospital and identify the risk factors associated with the acquisition of RSV-ALRTIs(Urban)
/200		Hospital (pediatric service)NasopharyngealRT-PCRHRSV (22.5%)Cross-sectional
Deberu
et al. [11]		2018–20192021–GhanaNo limitTo identify the presence of pathogens in sputum of suspected tuberculosis cases and their antimicrobial resistance patterns(Urban)
/264		Public Health LaboratoryExpectorationCulture
(MacConkey agar, blood agar, chocolate agar)		Klebsiella spp. (28%); M. tuberculosis (6.5%); Pseudomonas spp. (15.2%)Retrospective
Kouakou
et al. [40]		20212021Ivory Coast≤5 yearsTo provide general knowledge on the epidemiology of the virus, its seasonality and the signs associated with RSV in children aged 0 to 5 years in Côte d’Ivoire(Urban/rural)/5648Hospitals University (CHU) Regional Hospitals (CHR), General Hospitals (HG) Community Urban Health UnitNasopharyngealRT-qPCRHRSV (10%)Cross-sectional/descriptive
Kenmoe
et al. [41]		2011–20142021CameroonNo limitTo report the occurrence and phylogenetic relatedness of EVs and RVs detected in samples from patients of all ages suffering from ARI in Cameroon based on the sequences of the VP4/VP2 genomic region(Urban)
/974		Health centersNasopharyngealRT-PCRHRV/EV (16.4%)Cross-sectional
Birindwa
et al. [20]		2015–20172021Democratic Republic of the Congo≤5 yearsTo describe clinical characteristics and risk factors and to determine the occurrence of bacteria and viruses in the nasopharynx of hospitalized children with pneumonia in the Eastern DR Congo(Urban)
/2322		HospitalNasopharyngealMultiplex RT-PCR assay
Culture		H. influenzae (54%); S. pneumoniae (96%); HRV (73%); EV (17%); HRSV (7%);Cross-sectional
Ntagereka
et al. [42]		20212022Democratic Republic of the CongoNo limitTo investigate the prevalence of SARSCoV-2, influenza A and B, and other acute respiratory viruses among local patients with flu-like symptoms(Urban)
/1352		Hospital,
Health Center.		Oro-pharyngealRT-PCRSARS-CoV-2 (13.9%), Flu A (5.6%), Flu B (0.9%)Cross-sectional
Kafintu-
Kwashie et al. [43]		2015–20162022Ghana<5 yearsTo investigate and genotype respiratory syncytial virus and human metapneumovirus in children presenting with ALRTI infections at the Princess Marie Louis Children’s Hospital in Accra, Ghana(Urban)
/188		HospitalNasopharyngealTwo-step RT-PCRHRSV (11.4); HMPV (1.7%);Cross-sectional
Kolawole
et al. [44]		20172017Nigeria<14 yearsTo investigate if clinical cases may describe the entire picture of ARI among children in Nigeria(Urban)
/91		Community
Hospital		NasopharyngealPCRHcoV OC43 (13.3%); HcoV 229E/NL63 (12.5%)Cross-sectional
Ukuli et al. [45]2008–20162023UgandaNo limitTo identify and characterize new and re-emerging adenoviruses, which is important in the prevention and control of disease outbreaks as it would aid in predicting and preparing for future disease occurrences2298HospitalNasopharyngealPCRHAdV (9.8%)Retrospective
Feikin et al. [46]2007–20102012KenyaNo limitTo report bacterial and viral etiologies of ARI by age group, hospitalization status, HIV infection status and season. We also provide incidence by etiology, adjusted for healthcare seeking and presence of pathogens in asymptomatic controls(Rural)
/3046		Community
Hospital		Naso/Oro-pharyngeal
Blood
Urine		RT-qPCR
Culture		HRV/EV (33%); Flu A (22%); S. pneumoniae (3%); Salmonella sp. (3%)Cross-sectional
Fokam et al. [47]2020–20212022CameroonNo limitTo conduct a study in a large number of individuals tested for the presence of SARS-CoV-2 by PCR during the first epidemiological wave, to shed more light on the epidemiological, virological and clinical characteristics of COVID-19 in CameroonUrban/14119Center for researchNasopharyngealRT-PCRSARS-CoV-2 (12.7%)Cross-sectional
Dorkenoo et al. [48]20202022TogoNo limitTo estimate the prevalence of malaria and COVID-19 in febrile patients in LoméUrban/243Community health center of Legbassito; Hospital of Bè; Centre Hospitalier Universitaire CampusNasopharyngealGeneXpertSARS-CoV-2 (7.4%)Cross-sectional
Alber et al. [49]2020–20212022MaliNo limitTo estimate the degree of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) transmission among health care workers (HCWs) and the general population in
a West African setting		Urban/2392Referral and community health centerOro-pharyngealRT-PCRSARS-CoV-2 (2.8%)Cohort
Khairy et al. [50]2020–20212023Sudan<19 yearsTo describe the epidemiology of COVID-19 in children and adolescents in Sudan during 2020–2021Urban/3150Not indicatedNasopharyngealPCRSARS-CoV-2 (44%)Cross-sectional
Mulenga et al. [51]20202021ZambiaNo limitTo estimate SARS-CoV-2 prevalence in six districts of Zambia in July 2020, using a population-based household surveyUrban/2848HouseholdsNasopharyngealRT-PCRSARS-CoV-2 (7.6%)Cross-sectional
Abbreviations: HRSV: Human Respiratory Syncytial Virus; HRV: Human Rhinovirus; HAdV: Human Adenovirus; Flu A/B: Influenza viruses A/B type; HPIV 1–4: Human Parainfluenza viruses 1–4 types; EV: Enterovirus; hCoV: Human Coronavirus; hMPV: Human Metapnemovirus; hBoV: Human Bocavirus; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; HIV: Human Immunodeficiency Virus; S. pneumoniae: Streptococcus pneumoniae; S. aureus: Staphylococcus aureus; H. influenza b: Haemophilus influenzae b type; K. pneumoniae: Klebsiella pneumoniae; P. aeruginosa: Pseudomonas aeruginosa; M. tuberculosis: Mycobacterium tuberculosis; RT-qPCR: quantitative Real Time Polymerase Chain Reaction; RT-PCR: Reverse Transcription Polymerase Chain Reaction.
Table 2. Summary of published studies carried out in hospitalized patients.
Table 2. Summary of published studies carried out in hospitalized patients.
ReferencesCollection PeriodYear of PublicationStudy CountryAge RangeStudy ObjectiveZone/Sample SizeStudy FrameworkType of SamplingDiagnostic MethodsProportion of PathogensType of Study
Lagare et al. [14]2010–20122015Niger<5 yearsTo document the prevalence of selected viral and bacterial infections among children <5 years of age hospitalized with severe acute respiratory illness (SARI)(Urban)/160HospitalNasopharyngealOne-step multiplex RT-PCRHRSV (35%); HRV (29%); HPIV (24%); S. pneumoniae (56%); H. inflenzae (12%)Retrospective
Lagare
et al. [19]		20152019Niger<5 yearsTo describe viral and bacterial infections among children aged younger than 5 years hospitalized with febrile ARI at two hospitals in Niamey, Niger’s capital city, and the reported clinical procedures.(Urban)/638HospitalExpectoration
/Nasopharyngeal		RT-qPCRHRSV (23.3%), HPIV (12.2%), HRV (9.4%), HAdV (9.4%), Flu A (8.1%)/S. pneumoniae (39%), S. aureus (12.2%), H. influenzae B (2.5%)Prospective
Wadilo
et al. [52]		2019–20222023Ethiopia<5 yearsTo estimate the contribution of respiratory viruses to LRTIs among hospitalized children younger than 5 years.(Urban)/420HospitalNaso/Oro-pharyngealRT-qPCRHRSVA/B (30.5%); HRV (18.6%); HBoV (16.2%); HMPV (23.3%); SARS-CoV-2 (0.47%)Prospective case–control
Baillie
et al. [53]		2011–20142021South Africa≤5 yearsTo focus on the clinical epidemiology of RV infection, overall and by site, and its interactions with other respiratory pathogens in children 1–59 months of age hospitalized with pneumonia and in community controls.(Urban)/4232HospitalNaso/Oro-pharyngealRT-PCRHRV (21%)Cross-sectional
Simusika
et al. [54]		2011–20122015Zambia<5 yearsTo detect upper respiratory pathogens in specimens that were previously laboratory-confirmed influenza negative, to investigate the relative frequency of isolation, seasonality, and clinical diagnosis of various pathogens identified from SARI patients(Urban)/496HospitalNaso/Oro-pharyngealSingleplex and multiplex rRT-PCRHRV (19.2%); HADV (16.8%); HRSV (15.2%); HMPV (4.7%); S. pneumoniae (54.8%); M. catarrhalis (46.2%); H. influenzae (40.7%)Cross-sectional
Loevinsohn
et al. [55]		2018–20192021ZambiaNo limitTo describe the diversity of pathogens in the nasopharynx among patients with respiratory infections presenting for care in rural Zambia and the prognostic implications of co-infection.(Rural)/671HospitalNasopharyngealRT-PCR (GeneXpert)Flu A (12.7%); Flu B (6.4%); HRSV (4.4%); HRV (26.13%); HPIV (2.08%) HMPV (1.01%); HCoV (6.27%); HAdV (2.63%); Bordetella pertussis (0.19%)Cross-sectional
Ouédraogo
et al. [56]		2010–20112016Burkina Faso<5 yearsTo investigate the prevalence of RSV viral infections in infants suffering from respiratory infections and hospitalized in the city of Ouagadougou, and to evaluate the clinical characteristics associated with the identification of RSV.(Urban)/209HospitalNasopharyngealRT-PCRHRSV (16.2%)Cross-sectional
Kenmoe [57]2011–20142017Cameroon<15 yearsTo determine the etiology of ARI in children hospitalized in Yaoundé, Cameroon, and to genetically characterize the HRSV and HMPV strains detected.(Urban)/822HospitalNasopharyngealPCR/RT-PCRHRSV (9%); HMPV (3.9%); HAdV (28.5%); Flu A/B (21.4%); HRV/EV (15.5%); HBoV (9.4%); HCoV (8.2%); HPIV (6.2%)Descriptive and cross-sectional
Sanou [58]2014–20152018Burkina Faso<5 yearsTo study the epidemiology and genetic diversity of viruses and bacteria involved in acute respiratory infections in children under five in Burkina Faso.(Urban)/584HospitalNasopharyngealPCRHRV (29.8%); HRSV (13%); HAdV (9.8%); HBoV (8.2%); HPIV (7.8%); HMPV (6.2%); HCoV (3.1%); Flu A/B (12.3%); Flu C (2.9%)Cross-sectional
O’Callaghan-Gordo et al. [59]2006–20072011Mozambique<5 yearsTo present surveillance data on the epidemiology of several respiratory viruses associated with clinical pneumonia in children <5 years admitted to a rural hospital in Mozambique, a malaria-endemic area with high HIV prevalence(Rural)/394hospital-basedNasopharyngeal AspirateMultiplex RT-PCRHRV (41%); HAdV (21%); HRSV (11%); HMPV (8%); Flu A/B (8%); HPIV (7%); EV (4%)Cross-sectional
Jones et
al. [60]		2010–20132016Ghana<5 yearsTo concurrently conduct surveillance for severe acute respiratory infection and acute febrile illness (AFI) in three referral hospitals in Ghana to compare influenza-related epidemiologic data from the two syndrome-based surveillance platforms.(Urban)/1273HospitalNaso/Oro-pharyngealRT-PCRFlu A (55%); H1N1 (26%); H3N2 (29%); FluB (45%)Cross-sectional
Simeon
et al. [61]		2017–20182021Namibia<5 yearsTo formulate cumulative antibiograms for Intensive Care Units (ICUs) of referral hospitals in Namibia to guide future antibiotic use(Urban)/976HospitalExpectorationCultureK. pneumoniae (8.8%), Enterobacter sp. (22.2%); P. aeruginosa (37.5%)Retrospective
Analytical
Cross-sectional
Mveang Nzoghe
et al. [62]		20202021GabonNo limitTo Analyze and understand the dynamics of SARS-CoV-2 infection in this unique setting may help other countries in the fight against the COVID-19 pandemic.Urban/3464Not indicatedNaso/Oro-pharyngeal and bloodRT-PCRSARS-CoV-2 (17.2%)Retrospective
Sebastião et al. [63]20212021AngolaNo limitTo study the prevalence of SARS-CoV-2 in parturients and the risk factors that may be related to SARS-CoV-2 transmission to newborns in Luanda, the capital city of Angola.Urban/3633HospitalNasopharyngealRT-PCRSARS-CoV-2 (0.4%)Cross-sectional
Table 3. Proportion of pathogens identified in the 43 articles studied, conducted in several countries.
Table 3. Proportion of pathogens identified in the 43 articles studied, conducted in several countries.
Proportion (%)Number of StudiesNumber of Countries
Virus
Human Respiratory Syncytial Virus0.6–592818
Human rhinovirus7.5–732414
Influenza virus A/B0.9–691913
Human adenovirus0.9–30.81713
Human Parainfluenza virus2–241310
HCoV (NL63, OC43, 229E, HKU-1)1.4–13.9108
Human Enterovirus2.9–25.5117
Human metapneumovirus1–23.3117
SARS-CoV-20.4–4499
Human bocavirus1.4–16.265
Bacteria
Streptococcus pneumoniae1–9689
Haemophilus influenzae type b2.5–5476
Klebsiella pneumoniae1.4–49.965
Staphylococcus aureus1.7–12.223
Pseudomonas aeruginosa1.4–37.533
Salmonella typhi1.6–321
Mycobacterium tuberculosis0–6.511
M. catarrhalis0–46.211
B. Pertussis0–0.111
Enterobacter sp.22.211
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Demboux Lyelet, J.E.; Mayengue, P.I.; Koukouikila-Koussounda, F.; Leroy, E.M.; Becquart, P.; Niama, F.R. Viral and Bacterial Etiology of Common Respiratory Infections in Children in Sub-Saharan Africa: A Systematic Review. Children 2025, 12, 1212. https://doi.org/10.3390/children12091212

AMA Style

Demboux Lyelet JE, Mayengue PI, Koukouikila-Koussounda F, Leroy EM, Becquart P, Niama FR. Viral and Bacterial Etiology of Common Respiratory Infections in Children in Sub-Saharan Africa: A Systematic Review. Children. 2025; 12(9):1212. https://doi.org/10.3390/children12091212

Chicago/Turabian Style

Demboux Lyelet, Jordy Exaucé, Pembe Issamou Mayengue, Félix Koukouikila-Koussounda, Eric M. Leroy, Pierre Becquart, and Fabien Roch Niama. 2025. "Viral and Bacterial Etiology of Common Respiratory Infections in Children in Sub-Saharan Africa: A Systematic Review" Children 12, no. 9: 1212. https://doi.org/10.3390/children12091212

APA Style

Demboux Lyelet, J. E., Mayengue, P. I., Koukouikila-Koussounda, F., Leroy, E. M., Becquart, P., & Niama, F. R. (2025). Viral and Bacterial Etiology of Common Respiratory Infections in Children in Sub-Saharan Africa: A Systematic Review. Children, 12(9), 1212. https://doi.org/10.3390/children12091212

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop